GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Alzamend Neuro Inc (FRA:9ZT1) » Definitions » 3-Year FCF Growth Rate

Alzamend Neuro (FRA:9ZT1) 3-Year FCF Growth Rate : -51.90% (As of Jan. 2024)


View and export this data going back to 2021. Start your Free Trial

What is Alzamend Neuro 3-Year FCF Growth Rate?

Alzamend Neuro's Free Cash Flow per Share for the three months ended in Jan. 2024 was €-0.29.

During the past 3 years, the average Free Cash Flow per Share Growth Rate was -51.90% per year. Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the average Free Cash Flow per Share growth rate.

During the past 5 years, the highest 3-Year average Free Cash Flow per Share Growth Rate of Alzamend Neuro was -51.90% per year. The lowest was -85.60% per year. And the median was -68.75% per year.


Competitive Comparison of Alzamend Neuro's 3-Year FCF Growth Rate

For the Biotechnology subindustry, Alzamend Neuro's 3-Year FCF Growth Rate, along with its competitors' market caps and 3-Year FCF Growth Rate data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Alzamend Neuro's 3-Year FCF Growth Rate Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Alzamend Neuro's 3-Year FCF Growth Rate distribution charts can be found below:

* The bar in red indicates where Alzamend Neuro's 3-Year FCF Growth Rate falls into.



Alzamend Neuro 3-Year FCF Growth Rate Calculation

This is the 3-year average growth rate of Free Cash Flow per Share. The growth rate is calculated using exponential compounding based on the latest four year annual data.

Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the average Free Cash Flow per Share growth rate.


Alzamend Neuro  (FRA:9ZT1) 3-Year FCF Growth Rate Explanation

Free Cash Flow per Share is the amount of Free Cash Flow per outstanding share of the company's stock. Free Cash Flow is considered one of the most important parameters to measure a company's earnings power by value investors because it is not subject to estimates of Depreciation, Depletion and Amortization (DDA). However, when we look at the Free Cash Flow, we should look from a long term perspective, because any year's Free Cash Flow can be drastically affected by the spending on Property, Plant, & Equipment (PPE) of the business in that year. Over the long term, Free Cash Flow should give pretty good picture on the real earnings power of the company. It's used in the calculation of Forward Rate of Return (Yacktman) %.


Alzamend Neuro 3-Year FCF Growth Rate Related Terms

Thank you for viewing the detailed overview of Alzamend Neuro's 3-Year FCF Growth Rate provided by GuruFocus.com. Please click on the following links to see related term pages.


Alzamend Neuro (FRA:9ZT1) Business Description

Traded in Other Exchanges
Address
3480 Peachtree Road NE, Second Floor Suite 103, Atlanta, GA, USA, 30326
Alzamend Neuro Inc is an early clinical-stage biopharmaceutical company. It is focused on developing novel products for the treatment of neurodegenerative diseases and psychiatric disorders, including Alzheimer's. Its mission is to develop and market safe and effective treatments. The company's pipeline consists of two novel therapeutic drug candidates, AL001 - a patented ionic cocrystal technology delivering lithium via a therapeutic combination of lithium, proline and salicylate, and AL002 - a patented method using a mutant-peptide sensitized cell as a cell-based therapeutic vaccine that seeks to restore the ability of a patient's immunological system to combat Alzheimer's.

Alzamend Neuro (FRA:9ZT1) Headlines

No Headlines